Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers
NCT06999590 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2025-06-05
Summary
The purpose of this study it to evaluate several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus matched standard of care controls in the management of nonhealing pressure ulcers.
Conditions
- Pressure Ulcer
- Ulcer
- Ulcer, Pressure
- Pressure Injury
Interventions
- OTHER
-
ACApatch™
Participants will receive weekly applications of ACApatch™ and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.
- OTHER
-
caregraFT™
Participants will receive weekly applications of caregraFT™ and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.
- OTHER
-
Standard of Care
Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance) until ulcer closure, or a maximum of 20 weeks, whichever occurs first.
Sponsors & Collaborators
-
ExtremityCare, LLC.
collaborator UNKNOWN -
SerenaGroup, Inc.
collaborator NETWORK -
Tiger Biosciences, LLC.
lead INDUSTRY
Principal Investigators
-
Thomas Serena, MD · Serena Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-20
- Primary Completion
- 2027-05-31
- Completion
- 2027-05-31
Countries
- United States
Study Locations
More Related Trials
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443 ·Status: RECRUITING ·Phase: PHASE4
-
A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers
NCT07126886 ·Status: RECRUITING ·Phase: PHASE4
-
An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds
NCT05494450 ·Status: TERMINATED ·Phase: NA
-
Cold Plasma Jet kINPen Med Versus Best Practice Wound Dressings
NCT04965805 ·Status: COMPLETED ·Phase: NA
-
AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers
NCT01819142 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers
NCT06618612 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
NCT06437028 ·Status: RECRUITING ·Phase: NA
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
NCT06449638 ·Status: RECRUITING ·Phase: NA
-
NPWTi on Closure of Chronic Pressure Sores
NCT05598398 ·Status: RECRUITING ·Phase: PHASE4
-
AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period
NCT05892341 ·Status: COMPLETED ·Phase: NA
-
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
NCT01396304 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial To Study The Anti-scarring Effect Of Cicatricell
NCT03020420 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Sharp Debridement for the Management of Chronic Wounds
NCT00990522 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
NCT06674980 ·Status: RECRUITING ·Phase: NA
-
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
NCT07089602 ·Status: RECRUITING ·Phase: PHASE4
-
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT02248077 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System
NCT01623882 ·Status: WITHDRAWN
-
A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds
NCT02120755 ·Status: WITHDRAWN ·Phase: PHASE4
-
Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds
NCT03662997 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Aurix Therapy in Venous Leg Ulcers
NCT02940587 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
NCT02718625 ·Status: TERMINATED ·Phase: PHASE4
-
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
NCT06283979 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Safety, and Performance of ConvaFoam™ Dressings in the Management of Indicated Chronic Wound Types.
NCT05632250 ·Status: COMPLETED ·Phase: NA
-
A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Pressure Ulcers
NCT02312570 ·Status: UNKNOWN ·Phase: NA
-
Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers
NCT06403605 ·Status: COMPLETED ·Phase: NA